Cargando…

Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma

Pancreatic adenocarcinoma remains one of the most aggressive cancers with an ongoing dismal survival rate despite some recent advances in treatment options. This is largely due to the typically late presentation and limited effective therapeutic options in advanced disease. There are numerous circul...

Descripción completa

Detalles Bibliográficos
Autores principales:	Loft, Matthew, Lee, Belinda, Tie, Jeanne, Gibbs, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789869/ https://www.ncbi.nlm.nih.gov/pubmed/31323810 http://dx.doi.org/10.3390/jpm9030037

Ejemplares similares

Circulating Tumour DNA Guided Adjuvant Chemotherapy Decision Making in Stage II Colon Cancer—A Clinical Vignette Study
por: To, Yat Hang, et al.
Publicado: (2023)

The Diverse Applications of Pancreatic Ductal Adenocarcinoma Organoids
por: Low, Ronnie Ren Jie, et al.
Publicado: (2021)

Circulating tumour DNA in the evolving treatment landscape of locally advanced rectal cancer: where does it fit in?
por: Piercey, Oliver, et al.
Publicado: (2023)

Noninvasive detection of pancreatic ductal adenocarcinoma using the methylation signature of circulating tumour DNA
por: Wu, Huanwen, et al.
Publicado: (2022)

Circulating Tumor DNA in Gastric Adenocarcinoma: Future Clinical Applications and Perspectives
por: Grizzi, Giulia, et al.
Publicado: (2023)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

ctDNA and Adjuvant Therapy for Colorectal Cancer: Time to Re-Invent Our Treatment Paradigm
por: Naidoo, Mahendra, et al.
Publicado: (2021)

Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumor DNA
por: Lee, Jee‐Soo, et al.
Publicado: (2019)

Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours
por: Sefrioui, David, et al.
Publicado: (2017)

Profiling tumour heterogeneity through circulating tumour DNA in patients with pancreatic cancer
por: Adamo, Patricia, et al.
Publicado: (2017)

Longitudinal profiling of circulating tumour DNA for tracking tumour dynamics in pancreatic cancer
por: Sivapalan, Lavanya, et al.
Publicado: (2022)

Clinical Applications of Circulating Tumour Cells and Circulating Tumour DNA in Non-Small Cell Lung Cancer—An Update
por: Kapeleris, Joanna, et al.
Publicado: (2022)

Circulating tumor DNA: toward evolving the clinical paradigm of pancreatic ductal adenocarcinoma
por: Topham, James T., et al.
Publicado: (2023)

Circulating Tumour DNA in Melanoma—Clinic Ready?
por: Tivey, Ann, et al.
Publicado: (2022)

Biology, vulnerabilities and clinical applications of circulating tumour cells
por: Ring, Alexander, et al.
Publicado: (2022)

Monitoring of circulating tumour DNA in advanced pancreatic ductal adenocarcinoma predicts clinical outcome and reveals disease progression earlier than radiological imaging
por: Edland, Karin Hestnes, et al.
Publicado: (2023)

Detection of Microsatellite Instability: State of the Art and Future Applications in Circulating Tumour DNA (ctDNA)
por: Gilson, Pauline, et al.
Publicado: (2021)

Relationship between circulating tumour DNA and skeletal muscle stores at diagnosis of pancreatic ductal adenocarcinoma: a cross-sectional study
por: Hanna, Lauren, et al.
Publicado: (2023)

DNA Methylation in Circulating Tumour DNA as a Biomarker for Cancer
por: Board, Ruth E, et al.
Publicado: (2008)

Circulating tumour cells as an indicator of early and systemic recurrence after surgical resection in pancreatic ductal adenocarcinoma
por: Park, Yejong, et al.
Publicado: (2021)

Circulating tumour DNA — looking beyond the blood
por: Tivey, Ann, et al.
Publicado: (2022)

Circulating Nucleic Acids as Novel Biomarkers for Pancreatic Ductal Adenocarcinoma
por: McGowan, Ryan, et al.
Publicado: (2022)

Circulating Cell-Free Tumour DNA in the Management of Cancer
por: Francis, Glenn, et al.
Publicado: (2015)

Circulating Tumour DNA in Muscle-Invasive Bladder Cancer
por: Tan, Melissa P., et al.
Publicado: (2018)

Development of circulating tumour DNA analysis for gastrointestinal cancers
por: Nakamura, Yoshiaki, et al.
Publicado: (2020)

Longitudinal monitoring of circulating tumour DNA improves prognostication and relapse detection in gastroesophageal adenocarcinoma
por: Openshaw, Mark R., et al.
Publicado: (2020)

Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Huerta, Marisol, et al.
Publicado: (2021)

Circulating tumour DNA in colorectal cancer management
por: Cohen, Ryan, et al.
Publicado: (2023)

Detection of mitochondrial DNA mutations in circulating mitochondria-originated extracellular vesicles for potential diagnostic applications in pancreatic adenocarcinoma
por: Vikramdeo, Kunwar Somesh, et al.
Publicado: (2022)

Evaluation of circulating tumor DNA as a prognostic biomarker for metastatic pancreatic adenocarcinoma
por: Guan, Shasha, et al.
Publicado: (2022)

Inflammation, Biomarkers and Immuno-Oncology Pathways in Pancreatic Cancer
por: Lee, Belinda, et al.
Publicado: (2019)

The Role of Circulating MicroRNAs in Patients with Early-Stage Pancreatic Adenocarcinoma
por: Eid, Michal, et al.
Publicado: (2021)

Circulating Tumour Cells, Circulating Tumour DNA and Circulating Tumour miRNA in Blood Assays in the Different Steps of Colorectal Cancer Management, a Review of the Evidence in 2019
por: Christou, Niki, et al.
Publicado: (2019)

Integrated circulating tumour DNA and cytokine analysis for therapy monitoring of ALK-rearranged lung adenocarcinoma
por: Angeles, Arlou Kristina, et al.
Publicado: (2023)

Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases
por: Bai, Kaixuan, et al.
Publicado: (2023)

Prognostic value of circulating tumour DNA in patients undergoing curative resection for pancreatic cancer
por: Hadano, Naoto, et al.
Publicado: (2016)

Clinical Application of Circulating Tumour Cells in Prostate Cancer: From Bench to Bedside and Back
por: León-Mateos, Luis, et al.
Publicado: (2016)

The role of DNA methylation in human pancreatic neuroendocrine tumours
por: English, Katherine A, et al.
Publicado: (2023)

Genomic profile of advanced breast cancer in circulating tumour DNA
por: Kingston, Belinda, et al.
Publicado: (2021)

Circulating tumour-derived nucleic acids in cancer patients: potential applications as tumour markers
por: Chan, K C A, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_n45ftjcqcp6gd711djj0mj1d6h